Related Experiment Video
Updated: May 27, 2026

08:46
A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
Published on: December 2, 2022
A high-content subtractive screen for selecting small molecules affecting internalization of GPCRs
Yong-Jun Kwon1, Weontae Lee, Auguste Genovesio
1Institut Pasteur-Korea, Gyeonggi-do, Korea.
Journal of Biomolecular Screening
|November 17, 2011
Summary
This study developed a high-content screening method to find specific drugs targeting single G-protein-coupled receptors (GPCRs). The approach successfully identified selective kinase and phosphatase inhibitors for individual GPCRs, overcoming challenges in drug discovery.
Area of Science:
- Pharmacology
- Cell Biology
- Drug Discovery
Background:
- G-protein-coupled receptors (GPCRs) are crucial for cellular signaling and are major drug targets.
- Identifying selective drugs for individual GPCRs is difficult due to shared cellular pathways.
Purpose of the Study:
- To develop and validate a high-content screening (HCS) method for identifying receptor-selective small molecules targeting GPCRs.
- To discover novel kinase and phosphatase inhibitors with specificity for individual GPCRs.
Main Methods:
- Screened 88 kinase and phosphatase inhibitors against seven agonist-induced GPCR internalization cell models.
- Utilized transferrin uptake assays in human embryonic kidney cells to assess general endocytosis.
- Excluded compounds affecting multiple receptors or general endocytosis to identify single-receptor-specific molecules.
Main Results:
- Identified selective compounds acting on single GPCRs from diverse chemical structures.
- The HCS approach successfully differentiated receptor-specific activities from non-specific effects.
- Demonstrated the ability to rapidly select compounds with high specificity for individual GPCRs.
Conclusions:
- High-content screening is an effective strategy for discovering selective GPCR-targeting molecules.
- This method facilitates the identification of specific inhibitors within the kinase/phosphatase inhibitor family.
- The findings offer a pathway for developing more precise therapeutics targeting specific GPCRs.

